Reports Q4 revenue $333M, consensus $329.25M. Boris Jordan, Chairman and CEO of Curaleaf (CURLF), stated, “We closed 2025 with clear momentum, delivering fourth-quarter revenue of $333 million. Revenue increased 5% sequentially and 2% year over year, bolstered by a broad-based return to growth in nearly all of our domestic markets despite a persistently challenging pricing environment. Our international team closed out an impressive year with $51 million in fourth quarter revenue representing 10% sequential growth and 65% year over year revenue growth. Adjusted gross margin expanded to 49%, up 20 basis points from last year as the benefits from productivity gains in our cultivation facilities outweighed price compression. Adjusted EBITDA totaled $69 million, or 21% of sales, inclusive of a 120 basis point drag from international.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf opens newest dispensary in Findlay, Ohio
- Curaleaf Closes Record US$500 Million Note Offering, Extends Debt Maturities to 2029
- Curaleaf Delays Special Meeting, Plans Combined Vote on Move to Delaware
- Curaleaf Raises US$500 Million in Landmark Cannabis Bond Offering to Fund Global Expansion
- Curaleaf Postpones Special Meeting to Combine With AGM for Delaware Shift Vote
